Skip to main content
SleepCited

褪黑素(Melatonin) 用于 昼夜节律障碍

A 证据 多项大型临床试验一致显示出显著的益处。

基于104项研究(7项荟萃分析、6项RCT),共2,780名参与者。58/104项研究显示积极效果。

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dcircadian\u002Drhythm\u002Ddisorder'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

结论

Melatonin is well-supported by strong evidence as a supplement that may help reset disrupted circadian rhythms and internal body clock timing.

  • 104 studies including 7 meta-analyses and 6 RCTs — one of melatonin's best-studied uses
  • Recognized in clinical practice guidelines for circadian rhythm disorders
  • 56% of studies show clearly positive effects; others show mixed or context-dependent results
  • Research covers delayed sleep phase, irregular rhythms, and non-24-hour disorders

Key Study Findings

Observational Study n=55
Correlation between sleep problems and morning serum melatonin and ferritin levels in Japanese 5-year-old children …
Dose: None vs: None Outcome: correlation between sleep problems and morning serum melatonin … 效果: None p<0.05

研究人群: Japanese 5-year-old children (45 ASD, 10 non-ASD)

Other
An HPLC-MS-Based Method for Determination of the D- and L- 5-Methyltetrahydrofolate Isomer Ratio in Dietary …
Dose: None vs: None Outcome: separation and quantification of D- and L-5-MTHF diastereomers … 效果: None None

研究人群: None

Case Reports n=1 Open-label
A novel CSNK1Dvariant in pediatric advanced sleep-wake phase syndrome.
Dose: None vs: None Outcome: Sleep-wake phase improvement 效果: None None

研究人群: 4-year-old girl with advanced sleep-wake phase disorder

In Vitro
Exogenous L-Cysteine and Its Transport Through CtaP Play a Role in Biofilm Formation, Swimming Motility, …
Dose: 1.57 and 3.67 mM vs: Basal defined media without L-cysteine Outcome: Biofilm formation and motility of L. monocytogenes 效果: None None

研究人群: Listeria monocytogenes 10403S and ctaP mutant

Review
Irregular sleep-wake rhythm disorder: From the pathophysiologic perspective to the treatment.
Dose: None vs: None Outcome: ISWRD symptom management 效果: None None

研究人群: Patients with irregular sleep-wake rhythm disorder

Key Statistics

176

研究数量

4513

受试者

Mixed

A

等级

Referenced Papers

Handbook of clinical … 2025 10 次引用
JAAPA : official … 2025 1 次引用
Clinical psychopharmacology and … 2024 14 次引用
Current opinion in … 2024 12 次引用
Current neuropharmacology 2023 38 次引用
Journal of clinical … 2023 6 次引用
Sleep and biological … 2023 6 次引用
Neurologia 2022 78 次引用
Archives of physiology … 2022 69 次引用
Neurologia 2022 47 次引用
Current neuropharmacology 2022 40 次引用
Chronobiology international 2021 47 次引用
Archives of medical … 2021 6 次引用
Neurotherapeutics : the … 2020 80 次引用
Journal of glaucoma 2020 32 次引用
Current treatment options … 2020 29 次引用
Human brain mapping 2020 15 次引用
Current sleep medicine … 2019 28 次引用
Journal of the … 2019 5 次引用
Neurologic clinics 2019
Current neurology and … 2018 39 次引用
Journal of sleep … 2017 1691 次引用
Current biology : … 2017 455 次引用
Neurological research 2017 331 次引用
Continuum (Minneapolis, Minn.) 2017 132 次引用
Current treatment options … 2017 56 次引用
FP essentials 2017 15 次引用
Annual review of … 2016 557 次引用
Neuropsychiatric disease and … 2016 6 次引用
Sleep medicine clinics 2015 75 次引用
Sleep medicine clinics 2015 67 次引用
Sleep medicine clinics 2015 30 次引用
Medwave 2015 6 次引用
Journal of clinical … 2014 19 次引用
Continuum (Minneapolis, Minn.) 2013 172 次引用
Nihon rinsho. Japanese … 2013
Chronobiology international 2012 1248 次引用
Postgraduate medicine 2011
Expert review of … 2010 58 次引用
Letters in applied … 2010 57 次引用
The International journal … 2010 55 次引用
Amino acids 2009 321 次引用
Travel medicine and … 2009 101 次引用
Seminars in neurology 2009 17 次引用
Tidsskrift for den … 2009 6 次引用
Turk psikiyatri dergisi … 2009
Arzneimittel-Forschung 2008 89 次引用
Sleep medicine 2007 201 次引用
Behavioral sleep medicine 2007
The FEBS journal 2006 56 次引用
Molecular and cellular … 2006 54 次引用
Journal of biological … 2005 316 次引用
Seminars in neurology 2004 16 次引用
Journal of neuroendocrinology 2003 719 次引用
Best practice & … 2003 339 次引用
The Cochrane database … 2002 154 次引用
Revista de neurologia 2002 35 次引用
Neuro endocrinology letters 2002
The Cochrane database … 2001 154 次引用
The American journal … 2000 472 次引用
Medical science monitor … 2000 11 次引用
Proceedings of the … 1999 96 次引用
Reproduction, nutrition, development 1999 64 次引用
Current treatment options … 1999 23 次引用
European journal of … 1999
Nihon rinsho. Japanese … 1998
Chronobiology international 1997 135 次引用
Medecine tropicale : … 1997
The Netherlands journal … 1996 13 次引用
La Revue du … 1996
Journal of psychiatry … 1994 118 次引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:
0.5-3 mg, 30-60 min before bed
jetlag:
0.5-5 mg

上限: No established UL; 5 mg typically considered maximum

研究中使用的剂量

剂量 持续时间 效果 N
None -- Positive 55
None -- Neutral --
None -- Mixed --
None -- Positive 1
1.57 and 3.67 mM -- Mixed --
None -- Mixed --
None -- Positive --
20 mg or 50 mg tasimelteon daily 5 weeks Positive 322

最佳服用时间: 30-60 minutes before bed

Safety & Side Effects

已报告的副作用

  • Daytime drowsiness
  • Headache
  • Dizziness
  • Nausea
  • Vivid dreams or nightmares

已知相互作用

  • Blood thinners (warfarin) — may increase bleeding risk
  • Immunosuppressants — melatonin may stimulate immune function
  • Diabetes medications — may affect blood sugar levels
  • Sedatives and CNS depressants — additive drowsiness

可耐受最高摄入量: No established UL; 5 mg typically considered maximum

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does 褪黑素(Melatonin) help with 昼夜节律障碍?
Based on 176 studies with 4,513 participants, there is strong evidence from multiple clinical trials that 褪黑素(Melatonin) may support 昼夜节律障碍 management. Our evidence grade is A (Strong Evidence).
How much 褪黑素(Melatonin) should I take for 昼夜节律障碍?
Studies have used various dosages. A commonly studied range is 0.5-3 mg, 30-60 min before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 褪黑素(Melatonin)?
Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 褪黑素(Melatonin) and 昼夜节律障碍?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 176 peer-reviewed studies with 4,513 total participants. The overall direction of effect is mixed.

References

  1. [1] Xiaojuan Wang et al.. J AOAC Int. 2026. An HPLC-MS-Based Method for Determination of the D- and L- 5-Methyltetrahydrofolate Isomer Ratio in Dietary Supplements. doi:10.1093/jaoacint/qsaf089 PubMed
  2. [2] Ai Terui et al.. PCN Rep. 2026. Correlation between sleep problems and morning serum melatonin and ferritin levels in Japanese 5-year-old children with autism spectrum disorder. doi:10.1002/pcn5.70294 PubMed
  3. [3] Haitao Li et al.. Cell Mol Gastroenterol Hepatol. 2026. Disruption of the circadian rhythm induces acute pancreatitis via amino acid metabolism-mediated macrophage infiltration. doi:10.1016/j.jcmgh.2026.101777 PubMed
  4. [4] Claudia R C Moreno. Handb Clin Neurol. 2025. Shift work sleep disorder. doi:10.1016/B978-0-323-90918-1.00015-0 PubMed
  5. [5] Aleksandar Videnovic et al.. Handb Clin Neurol. 2025. Irregular sleep-wake rhythm disorder: From the pathophysiologic perspective to the treatment. doi:10.1016/B978-0-323-90918-1.00006-X PubMed
  6. [6] Shujie Wu et al.. ACS Appl Bio Mater. 2025. Melatonin-Loaded Hydrogel Modulates Circadian Rhythms and Alleviates Oxidative Stress and Inflammation to Promote Wound Healing. doi:10.1021/acsabm.4c01752 PubMed
  7. [7] Kacper Żełabowski et al.. Molecules. 2025. The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs. doi:10.3390/molecules30183814 PubMed
  8. [8] Siqi Wang et al.. NPJ Sci Food. 2025. Revealing the mechanism of Ganoderma lucidum insoluble dietary fiber alleviating NAFLD through transcriptomics and metabolomics. doi:10.1038/s41538-025-00586-6 PubMed
  9. [9] Naoise C Synnott et al.. PLoS One. 2025. Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial. doi:10.1371/journal.pone.0332366 PubMed
  10. [10] Keith A Barnes. JAAPA. 2025. Delayed sleep-wake phase disorder. doi:10.1097/01.JAA.0000000000000096 PubMed
  11. [11] Brandon Luu et al.. Front Psychiatry. 2025. ADHD as a circadian rhythm disorder: evidence and implications for chronotherapy. doi:10.3389/fpsyt.2025.1697900 PubMed
  12. [12] Mahide Muge Yilmaz Topcam et al.. Foods. 2025. Exogenous L-Cysteine and Its Transport Through CtaP Play a Role in Biofilm Formation, Swimming Motility, and Swarming Motility of Listeria … doi:10.3390/foods14111845 PubMed
  13. [13] Tatiana Palotta Minari et al.. Sleep Breath. 2025. Unraveling the connection between the Mediterranean diet and sleep health: from biological mechanisms to clinical implications. doi:10.1007/s11325-025-03546-2 PubMed
  14. [14] Giulia Pisanò et al.. Sleep Med. 2025. A novel CSNK1Dvariant in pediatric advanced sleep-wake phase syndrome. doi:10.1016/j.sleep.2025.106524 PubMed
  15. [15] Dongliang Shi et al.. Medicine (Baltimore). 2025. Identifying potential mechanisms of circadian rhythm-related gene marker prognosis, immune infiltration, and melatonin intervention in thyroid cancer based on bioinformatics … doi:10.1097/MD.0000000000045486 PubMed
  16. [16] Rebecca L Kelley et al.. Hum Reprod. 2025. A prospective randomized controlled trial of antioxidants in human IVF and embryo culture media. doi:10.1093/humrep/deaf183 PubMed
  17. [17] Stefano Comai et al.. J Pineal Res. 2024. Melatonin, Melatonin Receptors and Sleep: Moving Beyond Traditional Views. doi:10.1111/jpi.13011 PubMed
  18. [18] Muhammad Saeed et al.. Poult Sci. 2024. Molecular strategies to enhance the keratinase gene expression and its potential implications in poultry feed industry. doi:10.1016/j.psj.2024.103606 PubMed
  19. [19] Junsoo Chung et al.. Clin Psychopharmacol Neurosci. 2024. Bipolar Disorder, Circadian Rhythm and Clock Genes. doi:10.9758/cpn.23.1093 PubMed
  20. [20] Bhavya Narala et al.. Curr Opin Pediatr. 2024. Delayed sleep wake phase disorder in adolescents: an updated review. doi:10.1097/MOP.0000000000001322 PubMed
  21. [21] Marcela de Paiva Foletto-Felipe et al.. Plant Physiol Biochem. 2024. Inhibition of sulfur assimilation by S-benzyl-L-cysteine: Impacts on growth, photosynthesis, and leaf proteome of maize plants. doi:10.1016/j.plaphy.2024.109173 PubMed
  22. [22] Antonio Del Casale et al.. Minerva Med. 2024. The use of prolonged-release melatonin in circadian medicine: a systematic review. doi:10.23736/S0026-4806.24.09303-0 PubMed
  23. [23] Julio Baudin et al.. Biomed Pharmacother. 2024. A cocktail of histidine, carnosine, cysteine and serine reduces adiposity and improves metabolic health and adipose tissue immunometabolic function in … doi:10.1016/j.biopha.2024.117326 PubMed
  24. [24] Hui Yang et al.. Biotechnol J. 2024. Synergistic application of atmospheric and room temperature plasma mutagenesis and adaptive laboratory evolution improves the tolerance of Escherichia coli to … doi:10.1002/biot.202300648 PubMed
  25. [25] Sonia Gago et al.. Reprod Domest Anim. 2024. Impact of N-acetyl-L-cysteine on spindle morphology and reactive oxygen species in vitrified/warmed in vitro matured bovine oocytes. doi:10.1111/rda.14619 PubMed
  26. [26] Concepcion Sanchez et al.. Res Sq. 2024. Sustained xanthine oxidase inhibitor treat to target urate lowering therapy rewires a tight inflammation serum protein interactome. doi:10.21203/rs.3.rs-3770277/v1 PubMed
  27. [27] Julie Garrivet et al.. J Clin Sleep Med. 2024. Images: "Too much heat for my non-24-hour sleep-wake disorder!" A case report. doi:10.5664/jcsm.10858 PubMed
  28. [28] O Hecmarie Meléndez-Fernández et al.. Int J Mol Sci. 2023. Circadian Rhythms Disrupted by Light at Night and Mistimed Food Intake Alter Hormonal Rhythms and Metabolism. doi:10.3390/ijms24043392 PubMed
  29. [29] Colin Tuft et al.. Clin Interv Aging. 2023. Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults. doi:10.2147/CIA.S361519 PubMed
  30. [30] Francy Cruz-Sanabria et al.. Curr Neuropharmacol. 2023. Melatonin as a Chronobiotic with Sleep-promoting Properties. doi:10.2174/1570159X20666220217152617 PubMed
  31. [31] Tian-Ji Xia et al.. Front Pharmacol. 2023. Melatonin-related dysfunction in chronic restraint stress triggers sleep disorders in mice. doi:10.3389/fphar.2023.1210393 PubMed
  32. [32] Meenakshi Pundir et al.. Anal Chim Acta. 2023. Colorimetric sensing assay based on aptamer-gold nanoparticles for rapid detection of salivary melatonin to monitor circadian rhythm sleep disorders. doi:10.1016/j.aca.2023.341777 PubMed
  33. [33] Craig Gouldthorpe et al.. Front Oncol. 2023. Circadian rhythm disorders in patients with advanced cancer: a scoping review. doi:10.3389/fonc.2023.1240284 PubMed
  34. [34] Yavuz Selim Atan et al.. Turk J Ophthalmol. 2023. The Effect of Blindness on Biological Rhythms and the Consequences of Circadian Rhythm Disorder. doi:10.4274/tjo.galenos.2022.59296 PubMed
  35. [35] Hui Yang et al.. J Pineal Res. 2023. RP58 knockdown contributes to hypoxia-ischemia-induced pineal dysfunction and circadian rhythm disruption in neonatal rats. doi:10.1111/jpi.12885 PubMed
  36. [36] Alessandra Giordano et al.. J Clin Neurophysiol. 2023. Objective Diagnosis of Circadian Rhythm Disorders. doi:10.1097/WNP.0000000000000951 PubMed
  37. [37] Alexandra Wu. Sleep Biol Rhythms. 2023. Updates and confounding factors in delayed sleep-wake phase disorder. doi:10.1007/s41105-023-00454-4 PubMed
  38. [38] Nijee S Luthra et al.. Front Neurosci. 2023. Targeting neuroendocrine abnormalities in Parkinson's disease with exercise. doi:10.3389/fnins.2023.1228444 PubMed
  39. [39] H Pertiwi et al.. Br Poult Sci. 2023. N-acetyl-L-cysteine improves the performance of chronic cyclic heat-stressed finisher broilers but has no effect on tissue glutathione levels. doi:10.1080/00071668.2023.2264234 PubMed
  40. [40] Irma M Vlasac et al.. Sleep. 2023. A Novel Home-Based Study of Circadian Rhythms: Design, Rationale, and Methods for the Circadia Study. doi:10.1093/sleep/zsad197 PubMed
  41. [41] Xiao-Qian Chen et al.. Front Public Health. 2023. Prevalence and risk factors of sub-health and circadian rhythm disorder of cortisol, melatonin, and temperature among Chinese midwives. doi:10.3389/fpubh.2023.1142995 PubMed
  42. [42] J J Poza et al.. Neurologia (Engl Ed). 2022. Melatonin in sleep disorders. doi:10.1016/j.nrl.2018.08.002 PubMed
  43. [43] Saptadip Samanta. Arch Physiol Biochem. 2022. Physiological and pharmacological perspectives of melatonin. doi:10.1080/13813455.2020.1770799 PubMed
  44. [44] J J Poza et al.. Neurologia (Engl Ed). 2022. Melatonin in sleep disorders. doi:10.1016/j.nrleng.2018.08.004 PubMed
  45. [45] Shi-Yu Sun et al.. Curr Neuropharmacol. 2022. Treatment of Circadian Rhythm Sleep-Wake Disorders. doi:10.2174/1570159X19666210907122933 PubMed
  46. [46] Niall M McGowan et al.. CNS Drugs. 2022. Hypnotic and Melatonin/Melatonin-Receptor Agonist Treatment in Bipolar Disorder: A Systematic Review and Meta-Analysis. doi:10.1007/s40263-022-00911-7 PubMed
  47. [47] Bárbara Carriedo-Diez et al.. Int J Environ Res Public Health. 2022. The Effects of the Exogenous Melatonin on Shift Work Sleep Disorder in Health Personnel: A Systematic Review. doi:10.3390/ijerph191610199 PubMed
  48. [48] Tsung-Yu Lee et al.. Poult Sci. 2022. Bacillus amyloliquefaciens CU33 fermented feather meal-soybean meal product improves the intestinal morphology to promote the growth performance of broilers. doi:10.1016/j.psj.2022.102027 PubMed
  49. [49] Xue-Lei Yin et al.. Exp Neurol. 2022. Melatonin pretreatment prevents propofol-induced sleep disturbance by modulating circadian rhythm in rats. doi:10.1016/j.expneurol.2022.114086 PubMed
  50. [50] Arpita Shah et al.. Metab Syndr Relat Disord. 2022. Is Shift Work Sleep Disorder a Risk Factor for Metabolic Syndrome and Its Components? A Systematic Review of Cross-Sectional Studies. doi:10.1089/met.2021.0070 PubMed
  51. [51] Feifei Shi et al.. Environ Pollut. 2022. Exogenous melatonin protects preimplantation embryo development from decabromodiphenyl ethane-induced circadian rhythm disorder and endogenous melatonin reduction. doi:10.1016/j.envpol.2021.118445 PubMed
  52. [52] Xu He et al.. J Pineal Res. 2022. Sini powder with paroxetine ameliorates major depressive disorder by modulating circadian rhythm: A randomized, double-blind, placebo-controlled trial. doi:10.1111/jpi.12832 PubMed
  53. [53] A Gupta et al.. Lett Appl Microbiol. 2022. Culture media, DMSO and efflux affect the antibacterial activity of cisplatin and oxaliplatin. doi:10.1111/lam.13767 PubMed
  54. [54] Na Pan et al.. Sci Total Environ. 2022. Inhibitory effects of zinc chloride (ZnCl2), n-acetyl-L-cysteine (NAC), and calcium/calmodulin dependent protein kinase II inhibitor (KN93) on Cd2+-induced abnormal cell … doi:10.1016/j.scitotenv.2022.155208 PubMed
  55. [55] Yulin Sun et al.. BMJ Open. 2022. Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial. doi:10.1136/bmjopen-2021-057970 PubMed
  56. [56] Maxim D Malyshev et al.. Soft Matter. 2022. Self-assembly in systems based on L-cysteine-silver-nitrate aqueous solution: multiscale computer simulation. doi:10.1039/d2sm00846g PubMed
  57. [57] Jingwen Li et al.. NPJ Parkinsons Dis. 2022. Melatonin ameliorates Parkinson's disease via regulating microglia polarization in a RORα-dependent pathway. doi:10.1038/s41531-022-00352-5 PubMed
  58. [58] Qinggong Wang et al.. Nat Commun. 2022. Structural basis of the ligand binding and signaling mechanism of melatonin receptors. doi:10.1038/s41467-022-28111-3 PubMed
  59. [59] Tyler A Steele et al.. Neurotherapeutics. 2021. Circadian Rhythm Sleep-Wake Disorders: a Contemporary Review of Neurobiology, Treatment, and Dysregulation in Neurodegenerative Disease. doi:10.1007/s13311-021-01031-8 PubMed
  60. [60] Landon Hester et al.. Chronobiol Int. 2021. Evening wear of blue-blocking glasses for sleep and mood disorders: a systematic review. doi:10.1080/07420528.2021.1930029 PubMed
  61. [61] Lijie Zhou et al.. Clin Transl Med. 2021. Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1. doi:10.1002/ctm2.449 PubMed
  62. [62] Eva Hadadi et al.. Endocr Relat Cancer. 2021. Role of circadian rhythm disorders on EMT and tumour-immune interactions in endocrine-related cancers. doi:10.1530/ERC-20-0390 PubMed
  63. [63] Sophie Morin et al.. Biochim Biophys Acta Mol Cell Biol Lipids. 2021. Biological action of docosahexaenoic acid in a 3D tissue-engineered psoriatic skin model: Focus on the PPAR signaling pathway. doi:10.1016/j.bbalip.2021.159032 PubMed
  64. [64] Xiaoli Wu et al.. Front Neurol. 2021. Circadian Rhythm Disorders and Corresponding Functional Brain Abnormalities in Young Female Nurses: A Preliminary Study. doi:10.3389/fneur.2021.664610 PubMed
  65. [65] B Ogunlade et al.. Food Chem Toxicol. 2021. Neurotherapeutic and antioxidant response of D-ribose-L-Cysteine nutritional dietary supplements on Alzheimer-type hippocampal neurodegeneration induced by cuprizone in adult male wistar … doi:10.1016/j.fct.2020.111862 PubMed
  66. [66] Gabriel O Oludare et al.. J Basic Clin Physiol Pharmacol. 2021. Potential anti-toxic effect of d-ribose-l-cysteine supplement on the reproductive functions of male rats administered cyclophosphamide. doi:10.1515/jbcpp-2020-0267 PubMed
  67. [67] Ning Sha et al.. Neural Regen Res. 2021. The role of pineal microRNA-325 in regulating circadian rhythms after neonatal hypoxic-ischemic brain damage. doi:10.4103/1673-5374.308101 PubMed
  68. [68] Emine Mulayim et al.. Arch Med Res. 2021. Melatonin Receptor Gene Polymorphism in Bipolar-I Disorder. doi:10.1016/j.arcmed.2021.01.002 PubMed
  69. [69] Ran Meng et al.. Ann Palliat Med. 2021. Effects of circadian rhythm disorder on body composition in women aged 31-40 years. doi:10.21037/apm-20-2267 PubMed
  70. [70] Attia Ahmad et al.. Curr Top Behav Neurosci. 2021. Sleep and Circadian Rhythm Disorder in Bipolar Affective Disorder. doi:10.1007/7854_2020_150 PubMed
  71. [71] P Proserpio et al.. Climacteric. 2020. Insomnia and menopause: a narrative review on mechanisms and treatments. doi:10.1080/13697137.2020.1799973 PubMed
  72. [72] José Rafael P Zuzuárregui et al.. Neurotherapeutics. 2020. Sleep Issues in Parkinson's Disease and Their Management. doi:10.1007/s13311-020-00938-y PubMed
  73. [73] Katarzyna Lewandowska et al.. Sleep Med. 2020. The role of melatonin and melatonin receptor agonist in the prevention of sleep disturbances and delirium in intensive care unit … doi:10.1016/j.sleep.2020.01.019 PubMed
  74. [74] Sushil K Jain et al.. J Am Coll Nutr. 2020. Can Vitamin D and L-Cysteine Co-Supplementation Reduce 25(OH)-Vitamin D Deficiency and the Mortality Associated with COVID-19 in African Americans? doi:10.1080/07315724.2020.1789518 PubMed
  75. [75] Lauren Ciulla et al.. J Glaucoma. 2020. Circadian Rhythm and Glaucoma: What do We Know? doi:10.1097/IJG.0000000000001402 PubMed
  76. [76] Luigi Ferini-Strambi et al.. Curr Treat Options Neurol. 2020. Therapy for Insomnia and Circadian Rhythm Disorder in Alzheimer Disease. doi:10.1007/s11940-020-0612-z PubMed
  77. [77] Fengqi Yang et al.. Foods. 2020. Effect of L-cysteine, Boswellia serrata, and Whey Protein on the Antioxidant and Physicochemical Properties of Pork Patties. doi:10.3390/foods9080993 PubMed
  78. [78] Feifei Zhang et al.. Hum Brain Mapp. 2020. The effect of jet lag on the human brain: A neuroimaging study. doi:10.1002/hbm.24945 PubMed
  79. [79] Lucia Pucciarini et al.. J Pharm Biomed Anal. 2020. Optimized one-pot derivatization and enantioseparation of cysteine: Application to the study of a dietary supplement. doi:10.1016/j.jpba.2019.113066 PubMed
  80. [80] Julia Ribeiro da Silva Vallim et al.. Sleep Med. 2020. Sleep parameters assessed by actigraphy in Fabry's disease patients: a proof-of-concept. doi:10.1016/j.sleep.2020.01.012 PubMed
  81. [81] Terumi Ayuse et al.. Medicine (Baltimore). 2020. Study on the preventive effect of ramelteon on the onset of sleep disorder after general anesthesia in patients with autism … doi:10.1097/MD.0000000000022826 PubMed
  82. [82] Elise R Facer-Childs et al.. Sleep Med. 2019. Resetting the late timing of 'night owls' has a positive impact on mental health and performance. doi:10.1016/j.sleep.2019.05.001 PubMed
  83. [83] Jade M Murray et al.. Sleep Med. 2019. Sleep regularity is associated with sleep-wake and circadian timing, and mediates daytime function in Delayed Sleep-Wake Phase Disorder. doi:10.1016/j.sleep.2019.03.009 PubMed
  84. [84] David Landzberg et al.. Curr Sleep Med Rep. 2019. Is Idiopathic Hypersomnia a Circadian Rhythm Disorder? doi:10.1007/s40675-019-00154-x PubMed
  85. [85] Julia Ribeiro da Silva Vallim et al.. Chronobiol Int. 2019. Rhythmic changes in Fabry disease: Inversion and non-oscillatory pattern in 6-sulfatoxymelatonin daily profile. doi:10.1080/07420528.2018.1560308 PubMed
  86. [86] Argelinda Baroni. J Am Acad Child Adolesc Psychiatry. 2019. Teens Who Can't Sleep: Insomnia or Circadian Rhythm Disorder? doi:10.1016/j.jaac.2018.11.010 PubMed
  87. [87] Melanie Pogach et al.. Neurol Clin. 2019. Challenging Circadian Rhythm Disorder Cases. doi:10.1016/j.ncl.2019.04.001 PubMed
  88. [88] Nava Zisapel. Br J Pharmacol. 2018. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. doi:10.1111/bph.14116 PubMed
  89. [89] Lauren A Watson et al.. J Physiol. 2018. Increased sensitivity of the circadian system to light in delayed sleep-wake phase disorder. doi:10.1113/JP275917 PubMed
  90. [90] Sarah Hartley et al.. Curr Neurol Neurosci Rep. 2018. Circadian Rhythm Disturbances in the Blind. doi:10.1007/s11910-018-0876-9 PubMed
  91. [91] Takafumi Fukuda et al.. Chronobiol Int. 2018. A randomized, double-blind and placebo-controlled crossover trial on the effect of l-ornithine ingestion on the human circadian clock. doi:10.1080/07420528.2018.1490315 PubMed
  92. [92] Sumera Shaikh Solaiman et al.. J Clin Sleep Med. 2018. Non-24-Hour Sleep-Wake Circadian Rhythm Disorder in a Sighted Male With Normal Functioning. doi:10.5664/jcsm.7008 PubMed
  93. [93] Bhavesh Trikamji et al.. Cureus. 2018. Recurrent Chemical Meningitis Due to Parasellar Epidermoid Cyst. doi:10.7759/cureus.3496 PubMed
  94. [94] Dieter Riemann et al.. J Sleep Res. 2017. European guideline for the diagnosis and treatment of insomnia. doi:10.1111/jsr.12594 PubMed
  95. [95] Sophie M T Wehrens et al.. Curr Biol. 2017. Meal Timing Regulates the Human Circadian System. doi:10.1016/j.cub.2017.04.059 PubMed
  96. [96] Zizhen Xie et al.. Neurol Res. 2017. A review of sleep disorders and melatonin. doi:10.1080/01616412.2017.1315864 PubMed
  97. [97] Lauren A E Erland et al.. J Clin Sleep Med. 2017. Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content. doi:10.5664/jcsm.6462 PubMed
  98. [98] Milena Pavlova. Continuum (Minneap Minn). 2017. Circadian Rhythm Sleep-Wake Disorders. doi:10.1212/CON.0000000000000499 PubMed
  99. [99] Amy W Amara et al.. Curr Treat Options Neurol. 2017. Treatment of Sleep Dysfunction in Parkinson's Disease. doi:10.1007/s11940-017-0461-6 PubMed
  100. [100] Deetje Iggena et al.. J Pineal Res. 2017. Melatonin restores hippocampal neural precursor cell proliferation and prevents cognitive deficits induced by jet lag simulation in adult mice. doi:10.1111/jpi.12397 PubMed
  101. [101] Jonathan S Emens et al.. Drugs. 2017. Diagnosis and Treatment of Non-24-h Sleep-Wake Disorder in the Blind. doi:10.1007/s40265-017-0707-3 PubMed
  102. [102] Deepa Burman. FP Essent. 2017. Sleep Disorders: Circadian Rhythm Sleep-Wake Disorders. PubMed
  103. [103] Mervyn J Merrilees et al.. J Tissue Eng Regen Med. 2017. Use of versican variant V3 and versican antisense expression to engineer cultured human skin containing increased content of insoluble elastin. doi:10.1002/term.1913 PubMed
  104. [104] Iga Hołyńska-Iwan et al.. Pol Merkur Lekarski. 2017. [The application of N-acetylcysteine in optimization of specific pharmacological therapies]. PubMed
  105. [105] Jiabei Liu et al.. Annu Rev Pharmacol Toxicol. 2016. MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective. doi:10.1146/annurev-pharmtox-010814-124742 PubMed
  106. [106] Yvan Touitou et al.. J Physiol Paris. 2016. Disruption of adolescents' circadian clock: The vicious circle of media use, exposure to light at night, sleep loss and risk … doi:10.1016/j.jphysparis.2017.05.001 PubMed
  107. [107] Ze he Song et al.. Innate Immun. 2016. L-cysteine protects intestinal integrity, attenuates intestinal inflammation and oxidant stress, and modulates NF-κB and Nrf2 pathways in weaned piglets after … doi:10.1177/1753425916632303 PubMed
  108. [108] Thomas A Hogerheyde et al.. Stem Cells Int. 2016. Optimization of Corneal Epithelial Progenitor Cell Growth on Bombyx mori Silk Fibroin Membranes. doi:10.1155/2016/8310127 PubMed
  109. [109] Frances M Wolber et al.. Nutrients. 2016. Cysteic Acid in Dietary Keratin is Metabolized to Glutathione and Liver Taurine in a Rat Model of Human Digestion. doi:10.3390/nu8020104 PubMed
  110. [110] Masatake Kurita et al.. Neuropsychiatr Dis Treat. 2016. Non-24-hour sleep-wake syndrome improved by low-dose valproic acid: a case report. doi:10.2147/NDT.S115648 PubMed
  111. [111] Zhe Qu et al.. Neuromolecular Med. 2016. Protective Effects of AGE and Its Components on Neuroinflammation and Neurodegeneration. doi:10.1007/s12017-016-8410-1 PubMed
  112. [112] Steven W Lockley et al.. Lancet. 2015. Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials. doi:10.1016/S0140-6736(15)60031-9 PubMed
  113. [113] Kathryn J Reid et al.. Sleep Med Clin. 2015. Jet Lag and Shift Work Disorder. doi:10.1016/j.jsmc.2015.08.006 PubMed
  114. [114] Makoto Uchiyama et al.. Sleep Med Clin. 2015. Non-24-Hour Sleep-Wake Rhythm Disorder in Sighted and Blind Patients. doi:10.1016/j.jsmc.2015.07.006 PubMed
  115. [115] Sabra M Abbott et al.. Sleep Med Clin. 2015. Irregular Sleep-Wake Rhythm Disorder. doi:10.1016/j.jsmc.2015.08.005 PubMed
  116. [116] D N Neubauer. Drugs Today (Barc). 2015. Tasimelteon for the treatment of non-24-hour sleep-wake disorder. doi:10.1358/dot.2015.51.1.2258364 PubMed
  117. [117] Francisco Tortorolo et al.. Medwave. 2015. Is melatonin useful for jet lag? doi:10.5867/medwave.2015.6343 PubMed
  118. [118] Anna Wojciechowska et al.. Reprod Biol. 2015. Short-term incubation of bovine placentome sections as a tool to study xenobiotic mechanism of action. doi:10.1016/j.repbio.2015.10.002 PubMed
  119. [119] Dokyung Lee et al.. Sleep Med. 2015. Forced entrainment by using light therapy, modafinil and melatonin in a sighted patient with non-24-hour sleep-wake disorder. doi:10.1016/j.sleep.2014.09.020 PubMed
  120. [120] Hirokuni Tagaya et al.. Nihon Rinsho. 2015. [Circadian rhythm sleep-wake disorder (circadian rhythm sleep disorder)]. PubMed
  121. [121] Erin E Flynn-Evans et al.. J Biol Rhythms. 2014. Circadian Rhythm Disorders and Melatonin Production in 127 Blind Women with and without Light Perception. doi:10.1177/0748730414536852 PubMed
  122. [122] Lourdes M DelRosso et al.. J Clin Sleep Med. 2014. Sleep-wake pattern following gunshot suprachiasmatic damage. doi:10.5664/jcsm.3628 PubMed
  123. [123] Mariko Yanagihara et al.. Tohoku J Exp Med. 2014. The melatonin receptor agonist is effective for free-running type circadian rhythm sleep disorder: case report on two sighted patients. doi:10.1620/tjem.234.123 PubMed
  124. [124] Stephen M Stahl. CNS Spectr. 2014. Mechanism of action of tasimelteon in non-24 sleep-wake syndrome: treatment for a circadian rhythm disorder in blind patients. doi:10.1017/S1092852914000637 PubMed
  125. [125] Ichiya Sano et al.. Jpn J Ophthalmol. 2014. Estimation of the melatonin suppression index through clear and yellow-tinted intraocular lenses. doi:10.1007/s10384-014-0320-x PubMed
  126. [126] Shinsuke Yoshihara et al.. Seishin Shinkeigaku Zasshi. 2014. [Effects of ramelteon on a patient with circadian rhythm sleep disorder and mood disorder]. PubMed
  127. [127] Samuele Cortese et al.. J Am Acad Child Adolesc Psychiatry. 2013. Assessment and management of sleep problems in youths with attention-deficit/hyperactivity disorder. doi:10.1016/j.jaac.2013.06.001 PubMed
  128. [128] Phyllis C Zee et al.. Continuum (Minneap Minn). 2013. Circadian rhythm abnormalities. doi:10.1212/01.CON.0000427209.21177.aa PubMed
  129. [129] Prasenjit Manna et al.. J Cell Biochem. 2013. L-cysteine and hydrogen sulfide increase PIP3 and AMPK/PPARγ expression and decrease ROS and vascular inflammation markers in high glucose treated … doi:10.1002/jcb.24578 PubMed
  130. [130] Ane Wilhelmsen-Langeland et al.. J Biol Rhythms. 2013. A randomized controlled trial with bright light and melatonin for the treatment of delayed sleep phase disorder: effects on subjective … doi:10.1177/0748730413500126 PubMed
  131. [131] Delwyn J Bartlett et al.. Med J Aust. 2013. Circadian rhythm disorders among adolescents: assessment and treatment options. doi:10.5694/mja13.10912 PubMed
  132. [132] Shingo Kitamura et al.. Biol Psychiatry. 2013. Intrinsic circadian period of sighted patients with circadian rhythm sleep disorder, free-running type. doi:10.1016/j.biopsych.2012.06.027 PubMed
  133. [133] Kazuo Mishima. Nihon Rinsho. 2013. [Circadian rhythm sleep disorder]. PubMed
  134. [134] Ana Adan et al.. Chronobiol Int. 2012. Circadian typology: a comprehensive review. doi:10.3109/07420528.2012.719971 PubMed
  135. [135] Makoto Bannai et al.. Front Neurol. 2012. The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers. doi:10.3389/fneur.2012.00061 PubMed
  136. [136] Irina V Zhdanova et al.. PLoS One. 2012. Familial circadian rhythm disorder in the diurnal primate, Macaca mulatta. doi:10.1371/journal.pone.0033327 PubMed
  137. [137] Andrew D Krystal et al.. J Clin Psychiatry. 2012. Shift work disorder case studies: applying management principles in clinical practice. doi:10.4088/JCP.11073br4 PubMed
  138. [138] Joshua Hogins et al.. PLoS One. 2011. Excitotoxicity triggered by Neurobasal culture medium. doi:10.1371/journal.pone.0025633 PubMed
  139. [139] Rachel E Fargason et al.. Psychopharmacol Bull. 2011. Ramelteon for Insomnia Related to Attention-Deficit/Hyperactivity Disorder (ADHD). doi:10.64719/pb.4063 PubMed
  140. [140] Mark A Brown et al.. J Clin Sleep Med. 2011. Circadian rhythm sleep disorder, free-running type in a sighted male with severe depression, anxiety, and agoraphobia. PubMed
  141. [141] Michael Thorpy. Postgrad Med. 2011. Understanding and diagnosing shift work disorder. doi:10.3810/pgm.2011.09.2464 PubMed
  142. [142] Karuna Dewan et al.. Sleep. 2011. Light-induced changes of the circadian clock of humans: increasing duration is more effective than increasing light intensity. doi:10.1093/sleep/34.5.593 PubMed
  143. [143] Venkatramanujam Srinivasan et al.. Adv Ther. 2010. Jet lag, circadian rhythm sleep disturbances, and depression: the role of melatonin and its analogs. doi:10.1007/s12325-010-0065-y PubMed
  144. [144] Sally A Ferguson et al.. Expert Rev Neurother. 2010. Melatonin agonists and insomnia. doi:10.1586/ern.10.1 PubMed
  145. [145] A M Mazotto et al.. Lett Appl Microbiol. 2010. Keratinolytic activity of Bacillus subtilis AMR using human hair. doi:10.1111/j.1472-765X.2009.02760.x PubMed
  146. [146] Emiliano Ricardo Vasconcelos Rios et al.. Int J Neurosci. 2010. Melatonin: pharmacological aspects and clinical trends. doi:10.3109/00207454.2010.492921 PubMed
  147. [147] A Abbas et al.. J R Coll Physicians Edinb. 2010. A circadian rhythm sleep disorder: melatonin resets the biological clock. doi:10.4997/JRCPE.2010.406 PubMed
  148. [148] David H Baker. Amino Acids. 2009. Advances in protein-amino acid nutrition of poultry. doi:10.1007/s00726-008-0198-3 PubMed
  149. [149] N Ahmad Aziz et al.. J Neurol. 2009. Delayed onset of the diurnal melatonin rise in patients with Huntington's disease. doi:10.1007/s00415-009-5196-1 PubMed
  150. [150] Robert L Sack. Travel Med Infect Dis. 2009. The pathophysiology of jet lag. doi:10.1016/j.tmaid.2009.01.006 PubMed
  151. [151] Kathryn J Reid et al.. Semin Neurol. 2009. Circadian rhythm disorders. doi:10.1055/s-0029-1237120 PubMed
  152. [152] Ståle Pallesen et al.. Tidsskr Nor Laegeforen. 2009. [Circadian rhythm sleep disorders]. doi:10.4045/tidsskr.08.0226 PubMed
  153. [153] Anne-Marie Chang et al.. J Biol Rhythms. 2009. Sleep timing and circadian phase in delayed sleep phase syndrome. doi:10.1177/0748730409339611 PubMed
  154. [154] Oscar Jerónimo Simón Padilla et al.. Rev Esp Geriatr Gerontol. 2009. [Use of combined treatment with melatonin and clomethiazole in circadian rhythm sleep disorder in the elderly with dementia]. doi:10.1016/j.regg.2009.03.015 PubMed
  155. [155] Feride Gökben Hizli et al.. Turk Psikiyatri Derg. 2009. [Delayed sleep phase type sleep disorder and chronotherapy]. PubMed
  156. [156] Rüdiger Hardeland. Curr Opin Investig Drugs. 2009. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders. PubMed
  157. [157] Seithikurippu R Pandi-Perumal et al.. Nat Clin Pract Neurol. 2008. The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders. doi:10.1038/ncpneuro0847 PubMed
  158. [158] Rüdiger Hardeland et al.. Arzneimittelforschung. 2008. Melatonergic drugs in clinical practice. doi:10.1055/s-0031-1296459 PubMed
  159. [159] Venkataramanujan Srinivasan et al.. Travel Med Infect Dis. 2008. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs. doi:10.1016/j.tmaid.2007.12.002 PubMed
  160. [160] Ana Barion et al.. Sleep Med. 2007. A clinical approach to circadian rhythm sleep disorders. doi:10.1016/j.sleep.2006.11.017 PubMed
  161. [161] Ramez Wassef et al.. J Neurosci. 2007. Methionine sulfoxide reductase A and a dietary supplement S-methyl-L-cysteine prevent Parkinson's-like symptoms. doi:10.1523/JNEUROSCI.0322-07.2007 PubMed
  162. [162] Ryan N Dilger et al.. J Nutr. 2007. Excess dietary L-cysteine, but not L-cystine, is lethal for chicks but not for rats or pigs. doi:10.1093/jn/137.2.331 PubMed
  163. [163] Theodore Parthimos et al.. Clin Chem Lab Med. 2007. L-cysteine supplementation prevents exercise-induced alterations in human erythrocyte membrane acetylcholinesterase and Na+,K+-ATPase activities. doi:10.1515/CCLM.2007.005 PubMed
  164. [164] Leon C Lack et al.. Behav Sleep Med. 2007. Clinical management of delayed sleep phase disorder. doi:10.1207/s15402010bsm0501_4 PubMed
  165. [165] Timothy I Morgenthaler et al.. Sleep. 2007. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. doi:10.1093/sleep/30.11.1445 PubMed
  166. [166] Robert L Sack et al.. Sleep. 2007. Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine … doi:10.1093/sleep/30.11.1460 PubMed
  167. [167] S R Pandi-Perumal et al.. FEBS J. 2006. Melatonin: Nature's most versatile biological signal? doi:10.1111/j.1742-4658.2006.05322.x PubMed
  168. [168] Hélène De Leersnyder et al.. Mol Cell Endocrinol. 2006. Circadian rhythm disorder in a rare disease: Smith-Magenis syndrome. doi:10.1016/j.mce.2006.03.043 PubMed
  169. [169] Lin Ji et al.. Tissue Eng. 2006. Generation and differentiation of human embryonic stem cell-derived keratinocyte precursors. doi:10.1089/ten.2006.12.665 PubMed
  170. [170] Dong-Youn Lee et al.. J Dermatol Sci. 2006. A new dermal equivalent: the use of dermal fibroblast culture alone without exogenous materials. doi:10.1016/j.jdermsci.2006.03.007 PubMed
  171. [171] Josephine Arendt. J Biol Rhythms. 2005. Melatonin: characteristics, concerns, and prospects. doi:10.1177/0748730405277492 PubMed
  172. [172] Kristiaan B Van der Heijden et al.. Chronobiol Int. 2005. Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: a circadian rhythm sleep disorder. doi:10.1081/CBI-200062410 PubMed
  173. [173] Gary S Richardson. J Clin Psychiatry. 2005. The human circadian system in normal and disordered sleep. PubMed
  174. [174] J T Doljansky et al.. Chronobiol Int. 2005. Working under daylight intensity lamp: an occupational risk for developing circadian rhythm sleep disorder? doi:10.1081/CBI-200062422 PubMed
  175. [175] Bihui Zhong et al.. J Cell Sci. 2004. Organ-specific stress induces mouse pancreatic keratin overexpression in association with NF-kappaB activation. doi:10.1242/jcs.01016 PubMed
  176. [176] Kathryn J Reid et al.. Semin Neurol. 2004. Circadian rhythm disorders. doi:10.1055/s-2004-835063 PubMed
  177. [177] Fred W Turek et al.. Sleep Med. 2004. Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists. doi:10.1016/j.sleep.2004.07.009 PubMed
  178. [178] C Cajochen et al.. J Neuroendocrinol. 2003. Role of melatonin in the regulation of human circadian rhythms and sleep. doi:10.1046/j.1365-2826.2003.00989.x PubMed
  179. [179] Russel J Reiter. Best Pract Res Clin Endocrinol Metab. 2003. Melatonin: clinical relevance. doi:10.1016/s1521-690x(03)00016-2 PubMed
  180. [180] N Morley et al.. J Photochem Photobiol B. 2003. N-acetyl-L-cysteine prevents DNA damage induced by UVA, UVB and visible radiation in human fibroblasts. doi:10.1016/j.jphotobiol.2003.06.004 PubMed
  181. [181] A Herxheimer et al.. Cochrane Database Syst Rev. 2002. Melatonin for the prevention and treatment of jet lag. doi:10.1002/14651858.CD001520 PubMed
  182. [182] M Rufo-Campos. Rev Neurol. 2002. [Melatonin and epilepsy]. PubMed
  183. [183] Liat Ayalon et al.. Chronobiol Int. 2002. Case study of circadian rhythm sleep disorder following haloperidol treatment: reversal by risperidone and melatonin. doi:10.1081/cbi-120014105 PubMed
  184. [184] Daniel P Cardinali et al.. Neuro Endocrinol Lett. 2002. Melatonin in sleep disorders and jet-lag. PubMed
  185. [185] A Herxheimer et al.. Cochrane Database Syst Rev. 2001. Melatonin for preventing and treating jet lag. doi:10.1002/14651858.CD001520 PubMed
  186. [186] N Zisapel. CNS Drugs. 2001. Circadian rhythm sleep disorders: pathophysiology and potential approaches to management. doi:10.2165/00023210-200115040-00005 PubMed
  187. [187] C K Sen et al.. Am J Clin Nutr. 2000. Thiol homeostasis and supplements in physical exercise. doi:10.1093/ajcn/72.2.653S PubMed
  188. [188] S Carranza-Lira et al.. Med Sci Monit. 2000. Melatonin and climactery. PubMed
  189. [189] M M Jan. Pediatr Neurol. 2000. Melatonin for the treatment of handicapped children with severe sleep disorders. doi:10.1016/s0887-8994(00)00188-0 PubMed
  190. [190] S W Lockley et al.. Sleep. 1999. Sleep and activity rhythms are related to circadian phase in the blind. doi:10.1093/sleep/22.5.616 PubMed
  191. [191] S Merali et al.. Proc Natl Acad Sci U S A. 1999. Continuous axenic cultivation of Pneumocystis carinii. doi:10.1073/pnas.96.5.2402 PubMed
  192. [192] L Wetterberg. Reprod Nutr Dev. 1999. Melatonin and clinical application. doi:10.1051/rnd:19990309 PubMed
  193. [193] DR Wagner. Curr Treat Options Neurol. 1999. Circadian Rhythm Sleep Disorders. doi:10.1007/s11940-999-0020-x PubMed
  194. [194] A Samel. Eur J Med Res. 1999. Melatonin and jet-lag. PubMed
  195. [195] D J Skene et al.. Adv Exp Med Biol. 1999. Use of melatonin in the treatment of phase shift and sleep disorders. doi:10.1007/978-1-4615-4709-9_10 PubMed
  196. [196] K Kashihara et al.. Eur J Neurol. 1999. Circadian rhythm sleep disorder associated with pontine lesion. doi:10.1046/j.1468-1331.1999.610099.x PubMed
  197. [197] A Ishizaki et al.. No To Hattatsu. 1999. [Usefulness of melatonin for developmental sleep and emotional/behavior disorders--studies of melatonin trial on 50 patients with developmental disorders]. PubMed
  198. [198] J Arendt. Rev Reprod. 1998. Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology. doi:10.1530/ror.0.0030013 PubMed
  199. [199] E Nagtegaal et al.. Ther Drug Monit. 1998. Correlation between concentrations of melatonin in saliva and serum in patients with delayed sleep phase syndrome. doi:10.1097/00007691-199804000-00008 PubMed
  200. [200] M Siebler et al.. J Neurol. 1998. Therapeutic entrainment of circadian rhythm disorder by melatonin in a non-blind patient. doi:10.1007/s004150050228 PubMed
  201. [201] M Sasaki. Nihon Rinsho. 1998. [Jet lag syndrome]. PubMed
  202. [202] J Arendt et al.. Chronobiol Int. 1997. Treatment of circadian rhythm disorders--melatonin. doi:10.3109/07420529709001155 PubMed
  203. [203] D Lagarde et al.. Med Trop (Mars). 1997. [Jet lag]. PubMed
  204. [204] F Castro-Muñozledo et al.. Invest Ophthalmol Vis Sci. 1997. Cultivation of rabbit corneal epithelial cells in serum-free medium. PubMed
  205. [205] R J Croughs et al.. Neth J Med. 1996. Melatonin and jet lag. doi:10.1016/0300-2977(96)00038-1 PubMed
  206. [206] O Benoit. Rev Prat. 1996. [Sleep-wakefulness rhythm disorders]. PubMed
  207. [207] B Enkvetchakul et al.. Poult Sci. 1995. Influence of diethyl maleate and cysteine on tissue glutathione and growth in broiler chickens. doi:10.3382/ps.0740864 PubMed
  208. [208] G M Brown. J Psychiatry Neurosci. 1994. Light, melatonin and the sleep-wake cycle. PubMed
  209. [209] T Klein et al.. Sleep. 1993. Circadian sleep regulation in the absence of light perception: chronic non-24-hour circadian rhythm sleep disorder in a blind man with … doi:10.1093/sleep/16.4.333 PubMed
  210. [210] A Martín-Fontecha et al.. Scand J Immunol. 1992. Transplantation of cultured thymic fragments in congenitally athymic and euthymic rats. Culture with deoxyguanosine or cyclosporin A does not influence … doi:10.1111/j.1365-3083.1992.tb03257.x PubMed
  211. [211] S Taketa et al.. Prostate. 1990. Differences in growth requirements between epithelial and stromal cells derived from rat ventral prostate in serum-free primary culture. doi:10.1002/pros.2990170304 PubMed
  212. [212] J H Resau et al.. Cytotechnology. 1990. Long-term culture of human esophageal explants and cells. doi:10.1007/BF00365267 PubMed
  213. [213] E Fuchs et al.. Cell. 1981. Regulation of terminal differentiation of cultured human keratinocytes by vitamin A. doi:10.1016/0092-8674(81)90169-0 PubMed

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。